Abstract
The anabolic effect of intermittent treatment with parathyroid hormone (PTH) on cortical bone was investigated. Groups of rats were injected with human PTH (1–34) or PTH (1–84), 1.1, 3.3, 10, and 30 nmol/kg/day for 30 days. A dose-related increase in bone formation rate at the femoral middiaphysis was found at both the periosteum and the endosteum and also an increase in bone mass, with no change in the bone lengths or body weight gain of the rats. The highest mineral apposition rate, as analyzed by tetracycline labeling, was found at the periosteal postero-medial aspect and at the endosteal anterior aspect. This pattern of bone modeling was also found in the PTH-treated animals, although more and more areas were included in bone mineral apposition. The PTH treatments did not change the porosity of the cortical bone nor the concentration and biochemical stability of the collagen. The highest doses of PTH resulted in a slight reduction in the ash concentration of cortical bone. No differences were found between the effects of PTH (1–34) and PTH (1–84) on bone formation rate, bone mass, porosity, and biochemical parameters. Consequently, intermittent treatment with PTH increased the formation of cortical bone dose dependently, at both the periosteum and the endosteum and increased the bone mass of these growing rats, with no change in the body weight gain or femoral growth rate compared with the control animals. The responses of the cortical bone modeling were increased by the PTH treatments without changing its direction or pattern.
Similar content being viewed by others
References
Kalu DN, Doyle FH, Pennock J, Foster GV (1970) Parathyroid hormone and experimental osteosclerosis. Lancet. 1:1362–1366
Tam CS, Heersche JNM, Murray TM, Parsons JA (1982) Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration. Endocrinology. 110:506–512
Hock JM, Gera I, Fonseca J, Raisz LG (1988) Human parathyroid hormone-(l-34) increases bone mass in ovariectomized and orchidectomized rats. Endocrinology. 122:2899–2904
Hock JM, Hummert JR, Boyce R, Fonseca J, Raisz LG (1989) Resorption is not essential for the stimulation of bone growth by hPTH-(l-34) in rats in vivo. J Bone Miner Res. 4:449–458
Gunness-Hey M, Hock JM (1989) Loss of the anabolic effect of parathyroid hormone on bone after discontinuation of hormone in rats. Bone. 10:447–452
Hock JM, Fonseca J (1990) Anabolic effect of human synthetic parathyroid hormone-(l-34) depends on growth hormone. Endocrinology. 127:1804–1810
Liu C-C, Kalu DN (1990) Human parathyroid hormone-(l-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats. J Bone Miner Res. 5:973–982
Mosekilde L, Sogaard CH, Danielsen CC, Torring O, Nilsson MHL (1991) The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(l-34) and hPTH-(l-84). Endocrinology. 129:421–428
Ibbotson KJ, Orcutt CM, D’Souza SM, Paddock CL, Arthur JA, Jankowsky ML, Boyce RW (1992) Contrasting effects of parathyroid hormone and insulin-like growth factor I in an aged ovariectomized rat model of postmenopausal osteoporosis. J Bone Miner Res. 7:425–432
Slovik DM, Rosenthal DI, Doppelt SH, Potts JT Jr. Daly MA, Campbell JA, Neer RM (1986) Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D. J Bone Miner Res. 1:377–381
Hesch R-D, Busch U, Prokop M, Delling G, Rittinghaus E-F (1989) Increase of vertebral density by combination therapy with pulsatile l-38hPTH and sequential addition of calcitonin nasal spray in osteoporotic patients. Calcif Tissue Int. 44:176–180
Reeve J, Davies UM, Hesp R, McNally E, Katz D (1990) Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride. Br Med J. 301:314–318
Bradbeer JN, Arlot ME, Meunier PJ, Reeve J (1992) Treatment of osteoporosis with parathyroid peptide (hPTH 1-34) and oestrogen: increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone. Clin Endocrinol (Oxf). 37:282–289
McCarthy TL, Centrella M, Canalis E (1989) Parathyroid hormone enhances the transcript and polypeptide levels of insulinlike growth factor I in osteoblast-enriched cultures from fetal rat bone. Endocrinology. 124:1247–1253
Canalis E, Centrella M, Burch W, McCarthy TL (1989) Insulinlike growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. J Clin Invest. 83:60–65
Wronski TJ, Yen C-F, Qi H, Dann LM (1993) Parathyroid hormone is more effective than estrogen or biphosphonates for restoration of lost bone mass in ovariectomized rats. Endocrinology. 132:823–831
Delmas PD, Vergnaud P, Arlot ME, Pastoureau P, Meunier PJ (1991) The in vivo effect of hPTH-(l-34) is blunted whenbone resorption is blocked by a bisphosphonate (abstract no. 214). Am Soc Bone Miner Res, annual meeting, San Diego, CA
Ejersted C, Andreassen TT, Oxlund H, Jorgensen PH, Bak B, Häggblad J, Torring O, Nilsson MHL (in press) Human parathyroid hormone (1-34) and (1-84) increase the mechanical strength and thickness of cortical bone in rats.
Frost HM (1969) Tetracycline-based histological analysis of bone remodeling. Calcif Tissue Res. 3:211–237
Oxlund H, Jorgensen PH, Ortoft G, Andreassen TT (1991) Alterations in the cross-links of skin collagen of rats treated with biosynthetic growth hormone. Connect Tissue Res. 26:65–75
Stegemann H, Stalder KH (1967) Determination of hydroxyproline. Clin Chim Acta. 18:267–273
Sokal RR, Rohlf FJ (1981) Biometry. WH Freeman & Co, San Francisco
Frost HM (1992) Perspectives. The role of changes in mechanical usage set points in the pathogenesis of osteoporosis. J Bone Miner Res. 7:253–261
Raisz LG, Kream BE (1983) Regulation of bone formation. N Engl J Med. 309:29–35
Reeve J, Zanelli JM (1986) Parathyroid hormone and bone. Clin Sci. 71:231–238
Löwik CWGM, van Leeuwen JPTM, van der Meer JM, van Zeeland JK, Scheven BAA, Hermann-Erlee MPM (1985) A two-receptor model for the action of parathyroid hormone on osteoblasts: a role for intracellular free calcium and cAMP. Cell Calcium. 6:311–326
Torring O, Firek AF, Heath H III, Conover CA (1991) Parathyroid hormone and parathyroid hormone-related peptide stimulate insulin-like growth factor binding protein secretion by rat osteoblast-like cells through an adenosine 3′,5′-mono-phosphate-dependent mechanism. Endocrinology. 128:1006–1014
Acknowledgments
This investigation was supported by the Danish Medical Research Council, Nordisk Insulin Fond, Novo’s Fond, Aage Louis-Hansens Mindefond, and Fr0lund Nielsens Fond. The authors wish to thank C. Knaehus, L. P. Kristensen, E. K. Mik-kelsen, and M. Mortensen for skilled technical assistance, and M. Fischer for linguistic revision.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oxlund, H., Ejersted, C., Andreassen, T.T. et al. Parathyroid Hormone (1–34) and (1–84) Stimulate Cortical Bone Formation Both from Periosteum and Endosteum. Calcif Tissue Int 53, 394–399 (1993). https://doi.org/10.1007/BF03549782
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03549782